|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate assets | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Furniture and equipment | ||||||||||||||||||||
| Construction in progress | ||||||||||||||||||||
| Total real estate assets | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Real estate assets - net | ||||||||||||||||||||
| Investments in direct financing leases - net | ||||||||||||||||||||
| Real estate loans receivable - net | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total real estate investments | ||||||||||||||||||||
| Non-real estate loans receivable - net | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Contractual receivables - net | ||||||||||||||||||||
| Other receivables and lease inducements | ||||||||||||||||||||
| Contractual and other receivables - net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Secured borrowings | ||||||||||||||||||||
| Senior notes and other unsecured borrowings - net | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 299,111 shares as of June 30, 2026 and 295,539 shares as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Cumulative net earnings | ||||||||||||||||||||
| Cumulative dividends paid | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
